Lif works to ensure that the pharmaceutical industry has the best possible conditions to develop, market, distribute and provide information on medicinal products.
Lif has 41 members among these are Danish as well as foreign companies. Lif’s work includes all links in the companies’ value chain: Ensuring better conditions for research and innovation,
formulation of rules and legislation on regulatory conditions, productivity conditions and improved market access.
Lif has a vision of a healthier Denmark with fast and easy access for all to the best preventive health measures and medicines, a society that fosters growth, prosperity and sustainability.
We strive to ensure that companies involved in developing and producing new and innovative medicines enjoy the best possible framework conditions and that the industry is seen as socially responsible and as adding value to society.